These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 15935875
1. Viral vectors for use in the development of biodefense vaccines. Lee JS, Hadjipanayis AG, Parker MD. Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1293-314. PubMed ID: 15935875 [Abstract] [Full Text] [Related]
2. Fish vaccine antigens produced or delivered by recombinant DNA technologies. Leong JC, Anderson E, Bootland LM, Chiou PW, Johnson M, Kim C, Mourich D, Trobridge G. Dev Biol Stand; 1997 Jun 17; 90():267-77. PubMed ID: 9270855 [Abstract] [Full Text] [Related]
3. DNA vaccines for biodefense. Dupuy LC, Schmaljohn CS. Expert Rev Vaccines; 2009 Dec 17; 8(12):1739-54. PubMed ID: 19943766 [Abstract] [Full Text] [Related]
4. [Viral encephalitis caused by biowarfare agents]. Stienlauf S, Eisenkraft A, Robenshtok E, Hourvitz A. Harefuah; 2002 May 17; 141 Spec No():51-6, 121. PubMed ID: 12170555 [Abstract] [Full Text] [Related]
6. DNA vaccines for biodefence. Garmory HS, Perkins SD, Phillpotts RJ, Titball RW. Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1343-61. PubMed ID: 15935877 [Abstract] [Full Text] [Related]
7. Virus vaccines: principles and prospects. Melnick JL. Bull World Health Organ; 1989 Jun 17; 67(2):105-12. PubMed ID: 2663217 [Abstract] [Full Text] [Related]
8. The role of particle-mediated DNA vaccines in biodefense preparedness. Dean HJ, Haynes J, Schmaljohn C. Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1315-42. PubMed ID: 15935876 [Abstract] [Full Text] [Related]
9. Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness. MacLachlan NJ, Balasuriya UB, Davis NL, Collier M, Johnston RE, Ferraro GL, Guthrie AJ. Vaccine; 2007 Jul 26; 25(30):5577-82. PubMed ID: 17267078 [Abstract] [Full Text] [Related]
11. Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium. Ning JF, Zhu W, Xu JP, Zheng CY, Meng XL. Vaccine; 2009 Feb 11; 27(7):1127-35. PubMed ID: 19071178 [Abstract] [Full Text] [Related]
12. Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology. Middlebrook JL. Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1415-23. PubMed ID: 15896873 [Abstract] [Full Text] [Related]
13. Clinicopathologic features of viral agents of potential use by bioterrorists. Burgess TH, Steele KE, Schoneboom BA, Grieder FB. Clin Lab Med; 2001 Sep 17; 21(3):475-93, viii. PubMed ID: 11572138 [Abstract] [Full Text] [Related]
14. Poxviruses as vaccine vectors. Pastoret PP, Vanderplasschen A. Comp Immunol Microbiol Infect Dis; 2003 Oct 17; 26(5-6):343-55. PubMed ID: 12818621 [Abstract] [Full Text] [Related]
15. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice. Lee JS, Groebner JL, Hadjipanayis AG, Negley DL, Schmaljohn AL, Welkos SL, Smith LA, Smith JF. Vaccine; 2006 Nov 17; 24(47-48):6886-92. PubMed ID: 16828936 [Abstract] [Full Text] [Related]
17. Particulate delivery systems for biodefense subunit vaccines. Bramwell VW, Eyles JE, Oya Alpar H. Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1247-65. PubMed ID: 15935873 [Abstract] [Full Text] [Related]